Register entry
MSN Laboratories Private Limited,
Data as of · How to read this entry
- Registered sites
- 8
- Active NDC listings
- 275
- Labeller names
- 2
- Live patents
- 0
- Shortage listings
- 4
- Countries
- 2
- Base
- India
Authorisation
Registered operations
Analytical testing8Active ingredient (API) manufacture3Finished drug manufacture4Packaging1
Sites
Registered establishments
8| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| MSN LABORATORIES PRIVATE LIMITED | FORMULATIONS DIVISION, UNIT-II, SURVEY NOS. 1277& 1319 to 1324, NANDIGAMA (VILLAGE), NANDIGAMA (MANDAL), RANGAREDDY DISTRICT, TELANGANA 509228, India (IND) | Analytical testing, Finished drug manufacture | 3011033544650786952 |
| MSN LABORATORIES PRIVATE LIMITED | Unit- 05, Sy. Nos. (Parts of) 7,8,13 and 189, Chinna Chilkamarri, Chilkamarri (Chelka) Village, Farooqnagar Mandal,, Rangareddy, Telangana 509216, India (IND) | Analytical testing, Finished drug manufacture | 3035592613766384261 |
| MSN Laboratories Private LimitedRegistrant: MSN Laboratories Private Limited, | Formulation Division, Unit -04 Sy. No's (Parts of) : 884, 885 , 929, 930, 932, 933, 935, 937- 941 and 951 Mekaguda (Village), Nandigama (Mandal),, Rangareddy (District), Telangana 509228, India (IND) | Analytical testing, Finished drug manufacture | 3019516576854405955 |
| MSN Laboratories Private Limited | R&D Centre, Plot No. 12, Phase-IV, Sy.No. 119 to 140, 258, 275 to 280, IDA Pashamylaram, Pashamylaram (Village), Patancheru (Mandal), Sangareddy District, Telangana 502307, India (IND) | Analytical testing | 3005075182650683167 |
| MSN Laboratories Private Limited | Sy. No. 317, 320, 321, 322, 323, 604 & 605, Rudraram (Village), Patancheru (Mandal),, Sangareddy District, Telangana 502329, India (IND) | Analytical testing, Active ingredient (API) manufacture | 3005254981863363165 |
| MSN Laboratories Private Limited | Unit-II, Sy. No. 50, 53, 53/A, 54 & 54/A, Kardanur (Village), Patancheru (Mandal),, Sangareddy District, Telangana 502300, India (IND) | Analytical testing, Active ingredient (API) manufacture | 3008656542650534907 |
| MSN Laboratories Private Limited | Unit-III, Sy. No. 111/E & 111/EE, Cheriyal (Village), Kandi (Mandal),, Sangareddy District, Telangana 502285, India (IND) | Analytical testing, Active ingredient (API) manufacture | 3023132203738690985 |
| MSN PHARMACEUTICALS INC | 20, Duke Road, Piscataway, New Jersey (NJ) 08854, United States (USA) | Analytical testing, Finished drug manufacture, Packaging | 3014645733079229051 |
Alert
Drug shortage listings
4| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Bumetanide InjectionCardiovascular | Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-102-07) | Resolved | - | 13 Dec 201730 Sept 2026 |
| Bumetanide InjectionCardiovascular | Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01) | Resolved | - | 13 Dec 201730 Sept 2026 |
| Bumetanide InjectionCardiovascular | Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-101-07) | Resolved | - | 13 Dec 201730 Sept 2026 |
| Bumetanide InjectionCardiovascular | Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01) | Resolved | - | 13 Dec 201730 Sept 2026 |
Catalogue
Drug listings by form and route
275275 active NDC listings: 251 bulk ingredient, 24 human prescription drug. By marketing category: BULK INGREDIENT 251, ANDA 24.
| Dosage form | NDCs |
|---|---|
| powder | 246 |
| tablet | 8 |
| tablet, film coated | 8 |
| oil | 3 |
| tablet, for suspension | 3 |
| capsule, delayed release | 2 |
| liquid | 2 |
| capsule | 1 |
| injection, powder, lyophilized, for solution | 1 |
| kit | 1 |
| Route | NDCs |
|---|---|
| oral | 17 |
| sublingual | 5 |
| intravenous | 1 |
| subcutaneous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| msn laboratories private limited | 250 |
| msn laboratories private limited | 25 |
Catalogue
Marketed products
275Showing 150 of 275.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | AFATINIB DIMALEATE | powder | 54893-0054BULK INGREDIENT |
| - | Abemaciclib | powder | 54893-0098BULK INGREDIENT |
| - | Abiraterone | powder | 54893-0070BULK INGREDIENT |
| - | Abiraterone Acetate | powder | 54893-0019BULK INGREDIENT |
| - | Acalabrutinib | powder | 54893-0108BULK INGREDIENT |
| - | Acalabrutinib Maleate | powder | 54893-0507BULK INGREDIENT |
| - | Aclidinium Bromide | powder | 54893-0027BULK INGREDIENT |
| - | Adagrasib | powder | 54893-0525BULK INGREDIENT |
| - | Alcaftadine | powder | 14501-0020BULK INGREDIENT |
| - | Alectinib Hydrochloride | powder | 54893-0087BULK INGREDIENT |
| - | Alfuzosin Hydrochloride | powder | 14501-0003BULK INGREDIENT |
| - | Aliskiren Hemifumarate | powder | 14501-0062BULK INGREDIENT |
| - | Almotriptan Malate | powder | 14501-0073BULK INGREDIENT |
| - | Alogliptin Benzoate | powder | 14501-0024BULK INGREDIENT |
| - | Ambrisentan | powder | 14501-0059BULK INGREDIENT |
| - | Apalutamide | powder | 54893-0100BULK INGREDIENT |
| - | Apalutamide (Premix) | powder | 54893-0128BULK INGREDIENT |
| - | Apixaban | powder | 14501-0089BULK INGREDIENT |
| - | Arformoterol Tartrate | powder | 14501-0077BULK INGREDIENT |
| - | Asciminib Hydrochloride | powder | 54893-0517BULK INGREDIENT |
| Asenapine | ASENAPINE MALEATE | tablet, sublingual | 69539-057ANDA |
| Asenapine | ASENAPINE MALEATE | tablet, sublingual | 69539-058ANDA |
| Asenapine | ASENAPINE MALEATE | tablet, sublingual | 69539-059ANDA |
| Asenapine | ASENAPINE MALEATE | tablet, sublingual | 69539-060ANDA |
| Asenapine | ASENAPINE MALEATE | tablet, sublingual | 69539-245ANDA |
| - | Avanafil | powder | 14501-0090BULK INGREDIENT |
| - | Axitinib | powder | 54893-0032BULK INGREDIENT |
| - | Axitinib | powder | 54893-0043BULK INGREDIENT |
| - | Azacitidine | powder | 54893-0029BULK INGREDIENT |
| Azacitidine | Azacitidine | injection, powder, lyophilized, for solution, intravenous, subcutaneous | 69539-112ANDA |
| - | Azelastine Hydrochloride | powder | 14501-0048BULK INGREDIENT |
| - | Azilsartan Kamedoxomil | powder | 14501-0094BULK INGREDIENT |
| - | Baloxavir Marboxil | powder | 14501-0109BULK INGREDIENT |
| - | Baricitinib | powder | 14501-0104BULK INGREDIENT |
| - | Bazedoxifene | powder | 14501-0032BULK INGREDIENT |
| - | Belinostat | powder | 54893-0074BULK INGREDIENT |
| - | Belzutifan | powder | 54893-0515BULK INGREDIENT |
| - | Bendamustine hydrochloride | powder | 54893-0003BULK INGREDIENT |
| - | Bepotastine Besilate | powder | 14501-0088BULK INGREDIENT |
| - | Bexarotene | powder | 54893-0035BULK INGREDIENT |
| - | Bicalutamide | powder | 54893-0001BULK INGREDIENT |
| - | Bimatoprost | powder | 54893-0009BULK INGREDIENT |
| - | Binimetinib | powder | 54893-0119BULK INGREDIENT |
| - | Bortezomib | powder | 54893-0011BULK INGREDIENT |
| - | Bosentan | powder | 14501-0041BULK INGREDIENT |
| - | Bosutinib | powder | 54893-0041BULK INGREDIENT |
| - | Bosutinib | powder | 54893-0042BULK INGREDIENT |
| - | Bosutinib | powder | 54893-0048BULK INGREDIENT |
| - | Bumetanide | powder | 14501-0036BULK INGREDIENT |
| - | Cabazitaxel | powder | 54893-0016BULK INGREDIENT |
| - | Cabozantinib | powder | 54893-0130BULK INGREDIENT |
| - | Cabozantinib Fumarate | powder | 54893-0512BULK INGREDIENT |
| - | Cabozantinib(S)-Malate | powder | 54893-0058BULK INGREDIENT |
| - | Cabozantinib(S)-Malate | powder | 54893-0078BULK INGREDIENT |
| - | Capecitabine | powder | 54893-0002BULK INGREDIENT |
| - | Carboprost Tromethamine | powder | 54893-0023BULK INGREDIENT |
| - | Carfilzomib | powder | 54893-0037BULK INGREDIENT |
| - | Cariprazine Hydrochloride | powder | 14501-0035BULK INGREDIENT |
| - | Carmustine | powder | 54893-0055BULK INGREDIENT |
| - | Ceritinib | powder | 54893-0072BULK INGREDIENT |
| - | Cladribine | powder | 54893-0115BULK INGREDIENT |
| - | Cladribine Cyclodextrin | powder | 54893-0117BULK INGREDIENT |
| - | Clevidipine Butyrate | powder | 14501-0080BULK INGREDIENT |
| - | Clidinium Bromide | powder | 14501-0034BULK INGREDIENT |
| - | Clofarabine | powder | 54893-0028BULK INGREDIENT |
| - | Clopidogrel Bisulfate | powder | 14501-0026BULK INGREDIENT |
| - | Crizotinib | powder | 54893-0501BULK INGREDIENT |
| - | Cyclophosphamide Monohydrate | powder | 54893-0053BULK INGREDIENT |
| - | Dabigatran Etexilate Mesylate | powder | 14501-0071BULK INGREDIENT |
| - | Dabigatran Etexilate Oxalate | powder | 14501-0112BULK INGREDIENT |
| - | Dabrafenib Mesylate | powder | 54893-0052BULK INGREDIENT |
| - | Dacomitinib Monohydrate | powder | 54893-0103BULK INGREDIENT |
| - | Dapagliflozin | powder | 14501-0028BULK INGREDIENT |
| - | Dapagliflozin Propanediol | powder | 14501-0091BULK INGREDIENT |
| - | Darolutamide | powder | 54893-0107BULK INGREDIENT |
| - | Dasatinib | powder | 54893-0015BULK INGREDIENT |
| - | Dasatinib | powder | 54893-0047BULK INGREDIENT |
| - | Dasatinib Propylene Glycol | powder | 54893-0040BULK INGREDIENT |
| - | Decitabine | powder | 54893-0056BULK INGREDIENT |
| - | Deferasirox | powder | 14501-0049BULK INGREDIENT |
| Deferasirox | Deferasirox | tablet, for suspension, oral | 69539-021ANDA |
| Deferasirox | Deferasirox | tablet, for suspension, oral | 69539-022ANDA |
| Deferasirox | Deferasirox | tablet, for suspension, oral | 69539-023ANDA |
| Deferasirox | Deferasirox | tablet, oral | 69539-073ANDA |
| Deferasirox | Deferasirox | tablet, oral | 69539-074ANDA |
| Deferasirox | Deferasirox | tablet, oral | 69539-075ANDA |
| - | Deucravacitinib | powder | 54893-0521BULK INGREDIENT |
| - | Dexlansoprazole | powder | 14501-0057BULK INGREDIENT |
| - | Dexlansoprazole Sesquihydrate | powder | 14501-0060BULK INGREDIENT |
| - | Dexrazoxane | powder | 54893-0097BULK INGREDIENT |
| - | Diazoxide | powder | 14501-0096BULK INGREDIENT |
| - | Diazoxide Choline | powder | 14501-0117BULK INGREDIENT |
| Dimethyl Fumarate | Dimethyl fumarate | capsule, delayed release, oral | 69539-042ANDA |
| Dimethyl Fumarate | Dimethyl fumarate | capsule, delayed release, oral | 69539-043ANDA |
| Dimethyl Fumarate | Dimethyl Fumarate | kit | 69539-240ANDA |
| - | Docetaxel | powder | 54893-0008BULK INGREDIENT |
| - | Docetaxel Anhydrous | powder | 54893-0018BULK INGREDIENT |
| - | Dronedarone Hydrochloride | powder | 14501-0063BULK INGREDIENT |
| - | Duloxetine Hydrochloride | powder | 14501-0005BULK INGREDIENT |
| - | Dutasteride | powder | 14501-0006BULK INGREDIENT |
| - | Edaravone | powder | 14501-0100BULK INGREDIENT |
| - | Eltrombopag Olamine | powder | 14501-0018BULK INGREDIENT |
| - | Encorafenib | powder | 54893-0114BULK INGREDIENT |
| - | Enzalutamide | powder | 54893-0044BULK INGREDIENT |
| - | Eplerenone | powder | 14501-0007BULK INGREDIENT |
| - | Epoprostenol Sodium | powder | 54893-0004BULK INGREDIENT |
| - | Erlotinib Hydrochloride | powder | 54893-0012BULK INGREDIENT |
| - | Erlotinib Hydrochloride (Form-B) | powder | 54893-0067BULK INGREDIENT |
| - | Ertugliflozin | powder | 14501-0107BULK INGREDIENT |
| - | Ertugliflozin | powder | 14501-0110BULK INGREDIENT |
| - | Esmolol Hydrochloride | powder | 14501-0075BULK INGREDIENT |
| - | Everolimus | powder | 54893-0126BULK INGREDIENT |
| - | Ezetimibe | powder | 14501-0008BULK INGREDIENT |
| - | Finasteride | powder | 14501-0013BULK INGREDIENT |
| - | Fingolimod Hydrochloride | powder | 54893-0025BULK INGREDIENT |
| - | Fingolimod Hydrochloride (Form-I) | powder | 54893-0071BULK INGREDIENT |
| - | Fluvastatin Sodium | powder | 14501-0009BULK INGREDIENT |
| - | Formoterol Fumarate | powder | 14501-0087BULK INGREDIENT |
| - | Fosaprepitant Dimeglumine | powder | 14501-0064BULK INGREDIENT |
| - | Fosnetupitant Chloride Hydrochloride | powder | 14501-0105BULK INGREDIENT |
| - | Fruquitinib | powder | 54893-0524BULK INGREDIENT |
| - | Gefitinib | powder | 54893-0036BULK INGREDIENT |
| - | Gemcitabine Hydrochloride | powder | 54893-0006BULK INGREDIENT |
| - | Gilteritinib Fumarate | powder | 54893-0120BULK INGREDIENT |
| - | Glycerol Phenylbutyrate | liquid | 14501-0097BULK INGREDIENT |
| - | Ibrutinib (Form-A) | powder | 54893-0049BULK INGREDIENT |
| - | Ibrutinib (Form-C) | powder | 54893-0082BULK INGREDIENT |
| - | Ibrutinib (Form-M5) | powder | 54893-0102BULK INGREDIENT |
| - | Ibrutinib(Amorphous) | powder | 54893-0046BULK INGREDIENT |
| - | Iloprost | powder | 54893-0017BULK INGREDIENT |
| - | Imatinib Mesylate | powder | 54893-0005BULK INGREDIENT |
| - | Imatinib Mesylate | powder | 54893-0066BULK INGREDIENT |
| - | Indoximod | powder | 54893-0095BULK INGREDIENT |
| - | Isosulfan Blue | powder | 14501-0103BULK INGREDIENT |
| - | Ivacaftor | powder | 14501-0019BULK INGREDIENT |
| - | Ixazomib Citrate | powder | 54893-0084BULK INGREDIENT |
| - | Ketorolac Tromethamine | powder | 14501-0010BULK INGREDIENT |
| - | Lapatinib Ditosylate Monohydrate | powder | 54893-0110BULK INGREDIENT |
| - | Latanoprost | oil | 54893-0010BULK INGREDIENT |
| - | Latanoprostene Bunod | powder | 54893-0091BULK INGREDIENT |
| - | Lenalidomide | powder | 54893-0061BULK INGREDIENT |
| - | Lenalidomide Dimethyl Sulphoxide | powder | 54893-0065BULK INGREDIENT |
| - | Lenvatinib | powder | 54893-0080BULK INGREDIENT |
| - | Lenvatinib Mesylate | powder | 54893-0077BULK INGREDIENT |
| - | Lenvatinib Mesylate | powder | 54893-0112BULK INGREDIENT |
| - | Levothyroxine | powder | 54893-0131BULK INGREDIENT |
| - | Levothyroxine Sodium | powder | 54893-0125BULK INGREDIENT |
| - | Lofexidine Hydrochloride | powder | 14501-0098BULK INGREDIENT |
| - | Lorcaserin Hydrochloride | powder | 14501-0023BULK INGREDIENT |
| - | Lubiprostone | powder | 54893-0093BULK INGREDIENT |
Neighbours
Registered in the same town
12- NATCO PHARMA LIMITEDRangareddy, IND · 2 sites
- Hetero Drugs LimitedSangareddy district, IND · 2 sites
- Neuland Laboratories LimitedSangareddy District, IND · 2 sites
- Amneal Pharmaceuticals of New York, LLCPiscataway, NJ
- Coglate-Palmolive CompanyPiscataway, NJ
- Cohance Lifesciences LimitedRangareddy, IND
- L'Oreal USA Products IncPISCATAWAY, NJ
- Arch Pharmalabs LimitedSangareddy District, IND
- Aucta Pharmaceuticals, Inc.Piscataway, NJ
- Chromo Laboratories India Private LimitedSangareddy District, IND
- Kashiv BioSciences, LLCPiscataway, NJ
- APPCO PHARMA LLCPiscataway, NJ
Compare
Comparable companies in India
- Granules Pharmaceuticals Inc.8 sites · 302 NDC
- Hetero Labs Limited8 sites · 167 NDC
- Piramal Healthcare (Canada) Limited8 sites · 86 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- Glenmark Pharmaceuticals Inc., USA9 sites · 383 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Biocon Biologics Limited9 sites · 176 NDC
- Ipca Laboratories Limited7 sites · 77 NDC
- Indoco Remedies Limited7 sites · 58 NDC
- Viyash Scientific Limited9 sites · 58 NDC
Enquiry
Common questions
- Is MSN Laboratories Private Limited, FDA approved?
- MSN Laboratories Private Limited, holds 8 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are MSN Laboratories Private Limited,'s drugs manufactured?
- At registered sites in India, the United States. The FDA register lists RANGAREDDY DISTRICT; Rangareddy; Rangareddy (District); Sangareddy District; Piscataway, NJ. Registered operations: analytical testing, active ingredient (API) manufacture, finished drug manufacture, packaging.
- What drugs does MSN Laboratories Private Limited, make?
- 275 products are listed under MSN Laboratories Private Limited, in the openFDA NDC Directory, most often as powder; tablet; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.